China ramps up AI surveillance in face of coronavirus outbreak

Michael Walter | | Health Exec | Policy & Regulations
coronavirus_1.jpg

Big-name Chinese technology vendors have responded to the Wuhan coronavirus outbreak by using more AI surveillance on the general public than ever before.

Insider reported on the situation, explaining that vendors such as Megvii and Baidu are working to scan as many people as possible with their advanced AI systems. A solution from Baidu, for instance, can scan more than 200 people per minute and alerts someone if a body temperature of at least 99 degrees Fahrenheit is reported. A similar system from Megvii scans up to 15 people per second, from a distance of up to 16 feet, looking for high body temperatures.

Chinese subways are using artificial intelligence facial recognition scanners t…

So is this a necessary move or a reason for concern? The Insider notes that arguments are being made on both sides of that equation. Vendors and government officials say the surveillance is essential to help combat the coronavirus outbreak, but others argue that this “has given the Chinese government an argument for acquiring and monitoring private-sector data.”

Click below for the full story:

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”